beta3-Adrenergic Agonist [EPC]

beta3-Adrenergic Agonist [EPC] was reported 47774 times

Drugs of the beta3-Adrenergic Agonist [EPC] class are most commonly taken among patients reporting these side effects:

# Drug class Count Frequency
0 HEPATIC ENZYME 80 0.5369
1 HYPOCHOLESTEROLAEMIA 99 0.2805
2 FACET JOINT SYNDROME 663 0.2034
3 RESIDUAL URINE VOLUME INCREASED 23 0.1949
4 PERIPHERAL VENOUS DISEASE 658 0.1610
5 OVERLAP SYNDROME 103 0.1471
6 ONYCHOMADESIS 567 0.1350
7 BLEPHAROSPASM 825 0.1309
8 SWOLLEN JOINT COUNT 28 0.1120
9 RHEUMATIC FEVER 454 0.1017
10 BREAST CANCER STAGE III 657 0.1013
11 ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY POSITIVE 662 0.0923
12 ONYCHOMYCOSIS 405 0.0922
13 DUODENAL ULCER PERFORATION 652 0.0876
14 LUPUS VULGARIS 106 0.0841
15 INFUSION SITE REACTION 251 0.0839
16 NOCTURIA 975 0.0802
17 MUSCLE INJURY 631 0.0761
18 HYPERTONIC BLADDER 217 0.0751
19 FOLLICULITIS 773 0.0736
20 SUBCUTANEOUS DRUG ABSORPTION IMPAIRED 40 0.0713
21 DISLOCATION OF VERTEBRA 154 0.0675
22 NAIL DISORDER 570 0.0651
23 HYPERCHOLESTEROLAEMIA 626 0.0648
24 LIP DRY 588 0.0647
25 HELICOBACTER INFECTION 652 0.0634
26 BURSITIS 757 0.0623
27 URINE FLOW DECREASED 147 0.0615
28 PEMPHIGUS 769 0.0614
29 URGE INCONTINENCE 53 0.0609
30 FINGER DEFORMITY 283 0.0584
31 C-REACTIVE PROTEIN ABNORMAL 373 0.0581
32 BLADDER SPASM 108 0.0576
33 WOUND INFECTION 610 0.0556
34 DEEP VEIN THROMBOSIS POSTOPERATIVE 111 0.0554
35 X-RAY ABNORMAL 97 0.0542
36 LIVE BIRTH 420 0.0502
37 BACK INJURY 544 0.0500
38 HAND DEFORMITY 643 0.0490
39 JOINT RANGE OF MOTION DECREASED 626 0.0466
40 SWOLLEN JOINT COUNT INCREASED 147 0.0461
41 ADJUSTMENT DISORDER WITH DEPRESSED MOOD 93 0.0448
42 SYNOVITIS 801 0.0444
43 PERICARDITIS 742 0.0441
44 RETINITIS 75 0.0434
45 GRIP STRENGTH DECREASED 374 0.0425
46 MICTURITION URGENCY 476 0.0416
47 INABILITY TO AFFORD MEDICATION 409 0.0411
48 TASTE DISORDER 813 0.0400
49 BLADDER DISCOMFORT 47 0.0377
50 OBESITY 601 0.0377
51 PRODUCT LABEL CONFUSION 218 0.0374
52 PORPHYRIA ACUTE 53 0.0369
53 BLADDER PAIN 117 0.0368
54 URINARY INCONTINENCE 1082 0.0365
55 IRRITABLE BOWEL SYNDROME 771 0.0359
56 GLOSSODYNIA 790 0.0353
57 URINARY RETENTION 1142 0.0342
58 FIBROMYALGIA 720 0.0296
59 BONE EROSION 104 0.0294
60 CONGENITAL ANOMALY 226 0.0292
61 BLADDER OPERATION 34 0.0292
62 FORCED VITAL CAPACITY DECREASED 19 0.0291
63 URINARY HESITATION 68 0.0285
64 COELIAC DISEASE 276 0.0281
65 C-REACTIVE PROTEIN 26 0.0280
66 BRONCHIAL WALL THICKENING 20 0.0278
67 WOUND 751 0.0268
68 PERINEAL PAIN 19 0.0266
69 EPILEPSY 802 0.0262
70 CYSTITIS INTERSTITIAL 42 0.0261
71 POLLAKIURIA 1075 0.0258
72 BLADDER CATHETERISATION 24 0.0248
73 DEMENTIA WITH LEWY BODIES 27 0.0243
74 TYPE 2 DIABETES MELLITUS 803 0.0238
75 NEUROGENIC BLADDER 50 0.0237
76 BLADDER DISORDER 227 0.0228
77 UPPER AIRWAY OBSTRUCTION 20 0.0225
78 LIVER INJURY 550 0.0224
79 C-REACTIVE PROTEIN INCREASED 815 0.0224
80 SPUTUM RETENTION 22 0.0222
81 LIVER FUNCTION TEST INCREASED 477 0.0222
82 IMPAIRED HEALING 725 0.0221
83 NIGHT SWEATS 711 0.0220
84 RHEUMATOID FACTOR POSITIVE 125 0.0216
85 ON AND OFF PHENOMENON 120 0.0216
86 SYSTEMIC LUPUS ERYTHEMATOSUS 763 0.0215
87 URINE OUTPUT INCREASED 56 0.0214
88 CONTRAINDICATED PRODUCT ADMINISTERED 646 0.0213
89 DRUG EFFECT LESS THAN EXPECTED 315 0.0212
90 EXOSTOSIS 189 0.0207
91 GAIT INABILITY 690 0.0206
92 DRY MOUTH 1652 0.0203
93 BONE MARROW OEDEMA 21 0.0203
94 ADVERSE REACTION 269 0.0203
95 INCONTINENCE 213 0.0201
96 PSORIATIC ARTHROPATHY 805 0.0198
97 FREEZING PHENOMENON 73 0.0197
98 THERAPEUTIC PRODUCT EFFECT VARIABLE 75 0.0193
99 STOMA SITE ERYTHEMA 36 0.0193
100 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 1358 0.0191
101 OSTEOARTHRITIS 809 0.0191
102 BLADDER DYSFUNCTION 19 0.0185
103 THERAPEUTIC PRODUCT EFFECT DECREASED 817 0.0182
104 ESSENTIAL HYPERTENSION 33 0.0180
105 INTENTIONAL PRODUCT MISUSE 1556 0.0178
106 STRESS URINARY INCONTINENCE 19 0.0177
107 NORMAL NEWBORN 96 0.0176
108 UPPER RESPIRATORY TRACT INFLAMMATION 20 0.0167
109 CYSTITIS NONINFECTIVE 22 0.0164
110 BLOOD CHOLESTEROL INCREASED 726 0.0156
111 LOWER RESPIRATORY TRACT INFECTION 707 0.0155
112 URINARY TRACT INFECTION BACTERIAL 39 0.0154
113 STOMA SITE DISCHARGE 42 0.0153
114 STOMA SITE HAEMORRHAGE 23 0.0149
115 DRUG TOLERANCE 75 0.0148
116 DYSURIA 543 0.0147
117 INFLAMMATION 761 0.0147
118 STOMA SITE INFECTION 19 0.0146
119 LUNG DISORDER 715 0.0146
120 DRUG EFFECT INCOMPLETE 522 0.0144
121 JOINT INSTABILITY 20 0.0143
122 INFUSION RELATED REACTION 943 0.0142
123 WALKING AID USER 92 0.0139
124 INHIBITORY DRUG INTERACTION 22 0.0139
125 URINE ODOUR ABNORMAL 81 0.0138
126 BLOOD PRESSURE DIASTOLIC ABNORMAL 35 0.0137
127 RED BLOOD CELL SEDIMENTATION RATE INCREASED 152 0.0137
128 BLISTER 758 0.0135
129 INTENTIONAL PRODUCT USE ISSUE 1182 0.0135
130 GASTROOESOPHAGEAL REFLUX DISEASE 1084 0.0135
131 STEROID DIABETES 20 0.0133
132 ULCER HAEMORRHAGE 90 0.0133
133 BREAST CANCER STAGE II 109 0.0131
134 URINARY TRACT DISORDER 59 0.0131
135 INFUSION SITE BRUISING 28 0.0130
136 ARTHROPATHY 705 0.0127
137 MOBILITY DECREASED 883 0.0123
138 MUSCULOSKELETAL PAIN 637 0.0121
139 REHABILITATION THERAPY 47 0.0121
140 WHEEZING 719 0.0121
141 AUTOIMMUNE DISORDER 118 0.0121
142 SPINAL CORD INJURY 21 0.0120
143 NECK PAIN 673 0.0120
144 CYSTITIS 380 0.0119
145 HYPERKINESIA 25 0.0118
146 ANAL INCONTINENCE 106 0.0118
147 STOMATITIS 698 0.0115
148 URINE ABNORMALITY 52 0.0114
149 INFUSION SITE DISCHARGE 20 0.0114
150 SLEEP DISORDER 805 0.0114
151 ENURESIS 46 0.0114
152 PRODUCT AVAILABILITY ISSUE 259 0.0114
153 SLEEP DEFICIT 24 0.0113
154 PUSTULAR PSORIASIS 39 0.0113
155 HEPATIC ENZYME INCREASED 761 0.0112
156 BREAST DISORDER 22 0.0108
157 DRUG-INDUCED LIVER INJURY 337 0.0107
158 BRADYKINESIA 63 0.0107
159 HEPATITIS 271 0.0106
160 BLOOD PRESSURE INCREASED 1602 0.0105
161 SCIATICA 166 0.0104
162 TREATMENT NONCOMPLIANCE 567 0.0104
163 MATERNAL EXPOSURE DURING PREGNANCY 915 0.0103
164 URINARY TRACT INFECTION 1744 0.0102
165 SPINAL STENOSIS 42 0.0102
166 LUPUS-LIKE SYNDROME 92 0.0101
167 LIVING IN RESIDENTIAL INSTITUTION 19 0.0101
168 PRODUCT COLOUR ISSUE 52 0.0101
169 PRESCRIBED OVERDOSE 195 0.0101
170 MIGRAINE 960 0.0100
171 PRESCRIBED UNDERDOSE 196 0.0098
172 PERIARTHRITIS 22 0.0097
173 DRUG INTOLERANCE 928 0.0096
174 CONFUSIONAL STATE 1548 0.0096
175 POSTURE ABNORMAL 31 0.0095
176 MICTURITION DISORDER 33 0.0095
177 BENIGN PROSTATIC HYPERPLASIA 49 0.0095
178 NONSPECIFIC REACTION 52 0.0095
179 MEMORY IMPAIRMENT 1302 0.0095
180 PHARYNGEAL ERYTHEMA 20 0.0094
181 THERAPEUTIC PRODUCT EFFECT DELAYED 43 0.0094
182 INFUSION SITE HAEMORRHAGE 31 0.0094
183 LOWER LIMB FRACTURE 181 0.0094
184 VOLVULUS 22 0.0093
185 SLEEP DISORDER DUE TO GENERAL MEDICAL CONDITION, INSOMNIA TYPE 60 0.0092
186 SWELLING 850 0.0091
187 PERIPHERAL SWELLING 1399 0.0091
188 SPONDYLITIS 33 0.0091
189 CLOSTRIDIUM TEST POSITIVE 20 0.0091
190 SLOW SPEECH 22 0.0091
191 HAEMORRHAGE URINARY TRACT 23 0.0090
192 EAR PAIN 175 0.0090
193 HALLUCINATION 672 0.0089
194 BLOOD PRESSURE SYSTOLIC ABNORMAL 22 0.0089
195 EYE INJURY 27 0.0089
196 BLOOD PRESSURE SYSTOLIC INCREASED 173 0.0089
197 HALLUCINATION, VISUAL 186 0.0088
198 ILL-DEFINED DISORDER 530 0.0087
199 JOINT SWELLING 1041 0.0086
200 HYPOAESTHESIA 1275 0.0085
201 VULVOVAGINAL PRURITUS 43 0.0085
202 RASH VESICULAR 41 0.0085
203 PROSTATOMEGALY 33 0.0084
204 SKIN ABRASION 39 0.0082
205 DELUSION 128 0.0082
206 MUSCULAR WEAKNESS 935 0.0082
207 DEMENTIA 229 0.0082
208 DRUG TOLERANCE DECREASED 23 0.0082
209 BLOOD URINE PRESENT 155 0.0082
210 WHEELCHAIR USER 36 0.0081
211 CHRONIC SINUSITIS 30 0.0080
212 FAECES HARD 31 0.0080
213 MUSCLE SPASTICITY 97 0.0079
214 HYPERTENSION 1665 0.0079
215 GENERAL PHYSICAL HEALTH DETERIORATION 908 0.0078
216 SHOULDER ARTHROPLASTY 21 0.0078
217 RHINORRHOEA 503 0.0078
218 PULMONARY FIBROSIS 148 0.0077
219 URINE ANALYSIS ABNORMAL 23 0.0077
220 RHEUMATOID ARTHRITIS 865 0.0076
221 DELIRIUM 258 0.0074
222 TREATMENT FAILURE 613 0.0074
223 PARANASAL SINUS DISCOMFORT 28 0.0074
224 CONSTIPATION 1611 0.0074
225 PHYSICAL DECONDITIONING 19 0.0074
226 INTERCEPTED MEDICATION ERROR 34 0.0073
227 DIZZINESS POSTURAL 71 0.0073
228 URINE OUTPUT DECREASED 64 0.0073
229 TONGUE DISCOMFORT 31 0.0073
230 OESOPHAGEAL DISORDER 28 0.0073
231 ORTHOSTATIC HYPOTENSION 126 0.0072
232 DRY THROAT 73 0.0072
233 INFUSION SITE SWELLING 45 0.0071
234 PARAESTHESIA 1115 0.0071
235 SKIN LACERATION 77 0.0071
236 INTENTIONAL DRUG MISUSE 148 0.0071
237 MACULOPATHY 25 0.0070
238 HEART RATE ABNORMAL 39 0.0070
239 INJURY 491 0.0070
240 DYSPEPSIA 686 0.0070
241 NASOPHARYNGITIS 1277 0.0069
242 ANXIETY DISORDER 23 0.0069
243 FALL 2289 0.0069
244 CHROMATURIA 155 0.0069
245 PERONEAL NERVE PALSY 39 0.0069
246 ABDOMINAL DISCOMFORT 1150 0.0068
247 INFUSION SITE ERYTHEMA 57 0.0068
248 GASTROINTESTINAL MOTILITY DISORDER 36 0.0067
249 BOWEL MOVEMENT IRREGULARITY 51 0.0067
250 FUNCTIONAL GASTROINTESTINAL DISORDER 23 0.0066
251 HEPATIC CIRRHOSIS 125 0.0066
252 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 114 0.0066
253 BLOOD PRESSURE FLUCTUATION 157 0.0065
254 MUSCLE SPASMS 1199 0.0065
255 SPINAL OPERATION 80 0.0065
256 ABDOMINAL PAIN UPPER 1337 0.0065
257 BLOOD PRESSURE ABNORMAL 129 0.0065
258 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 311 0.0065
259 BALANCE DISORDER 557 0.0064
260 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 109 0.0064
261 MUSCULOSKELETAL STIFFNESS 562 0.0064
262 ASPIRATION 70 0.0064
263 EXPOSURE DURING PREGNANCY 397 0.0064
264 KIDNEY INFECTION 125 0.0064
265 SKIN ODOUR ABNORMAL 25 0.0063
266 GOITRE 26 0.0063
267 GASTROINTESTINAL DISORDER 564 0.0063
268 PRODUCT ADMINISTRATION INTERRUPTED 49 0.0062
269 HYPOVENTILATION 20 0.0061
270 MATERNAL EXPOSURE TIMING UNSPECIFIED 23 0.0061
271 DYSSTASIA 178 0.0061
272 DRUG PRESCRIBING ERROR 117 0.0061
273 FREQUENT BOWEL MOVEMENTS 163 0.0060
274 DRY EYE 301 0.0060
275 SLEEP APNOEA SYNDROME 115 0.0060
276 INFUSION SITE PRURITUS 19 0.0060
277 WHITE BLOOD CELL COUNT ABNORMAL 38 0.0059
278 INITIAL INSOMNIA 61 0.0059
279 PRODUCT DISPENSING ERROR 129 0.0059
280 KNEE ARTHROPLASTY 124 0.0059
281 DYSKINESIA 238 0.0059
282 MUSCLE RIGIDITY 70 0.0058
283 BACK DISORDER 95 0.0058
284 DISCOMFORT 355 0.0058
285 VULVOVAGINAL PAIN 28 0.0058
286 URTICARIA 970 0.0058
287 FOOT DEFORMITY 64 0.0058
288 DEVICE KINK 21 0.0058
289 MULTIPLE SCLEROSIS 275 0.0057
290 HEAD INJURY 182 0.0057
291 UROSEPSIS 53 0.0057
292 THYROID MASS 22 0.0057
293 IMMOBILE 25 0.0057
294 MOUTH SWELLING 33 0.0057
295 INFUSION SITE PAIN 73 0.0057
296 FAECALOMA 31 0.0057
297 GAIT DISTURBANCE 1077 0.0056
298 MIDDLE INSOMNIA 105 0.0056
299 JOINT STIFFNESS 147 0.0056
300 MYASTHENIA GRAVIS 45 0.0056
301 HOSPICE CARE 55 0.0056
302 CONCUSSION 43 0.0055
303 INJECTION SITE REACTION 382 0.0055
304 HIP ARTHROPLASTY 85 0.0055
305 VITAMIN D DEFICIENCY 54 0.0055
306 FAECES SOFT 40 0.0055
307 DEPRESSION 1249 0.0055
308 SEASONAL ALLERGY 77 0.0054
309 ABDOMINAL DISTENSION 566 0.0054
310 DRUG INEFFECTIVE 7142 0.0054
311 BLOOD PRESSURE DIASTOLIC DECREASED 40 0.0054
312 PRODUCT SIZE ISSUE 29 0.0054
313 PRODUCT DOSE OMISSION IN ERROR 152 0.0054
314 HIP SURGERY 29 0.0054
315 INCREASED TENDENCY TO BRUISE 49 0.0053
316 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 375 0.0053
317 MYOSITIS 47 0.0052
318 COMPRESSION FRACTURE 28 0.0052
319 UPPER-AIRWAY COUGH SYNDROME 43 0.0052
320 LIP SWELLING 173 0.0052
321 HYPERTENSIVE CRISIS 57 0.0051
322 HYPERLIPIDAEMIA 61 0.0051
323 OSTEOPOROSIS 209 0.0051
324 PROSTATIC DISORDER 28 0.0051
325 CONDITION AGGRAVATED 1543 0.0051
326 ALOPECIA 996 0.0051
327 CONTUSION 488 0.0051
328 DIZZINESS 2525 0.0051
329 BRONCHIECTASIS 34 0.0050
330 HOT FLUSH 379 0.0050
331 PELVIC FRACTURE 39 0.0050
332 PRODUCT RESIDUE PRESENT 27 0.0050
333 HALLUCINATIONS, MIXED 21 0.0050
334 COMMUNICATION DISORDER 19 0.0050
335 NEPHROGENIC ANAEMIA 23 0.0050
336 PRODUCT USE IN UNAPPROVED INDICATION 1223 0.0049
337 INSOMNIA 1314 0.0049
338 SINUS DISORDER 97 0.0049
339 CATARACT OPERATION 29 0.0049
340 THERAPY INTERRUPTED 349 0.0049
341 ORAL CANDIDIASIS 64 0.0049
342 INCORRECT PRODUCT ADMINISTRATION DURATION 105 0.0048
343 INSURANCE ISSUE 74 0.0048
344 JOINT DISLOCATION 51 0.0048
345 HIP FRACTURE 155 0.0048
346 RED CELL DISTRIBUTION WIDTH INCREASED 20 0.0048
347 LUMBAR VERTEBRAL FRACTURE 22 0.0048
348 NASAL DRYNESS 30 0.0048
349 WEIGHT FLUCTUATION 50 0.0048
350 PRODUCT QUALITY ISSUE 649 0.0048
351 RIB FRACTURE 98 0.0048
352 POLYP 31 0.0047
353 COGNITIVE DISORDER 221 0.0047
354 PRODUCT USE ISSUE 888 0.0047
355 SPINAL COMPRESSION FRACTURE 39 0.0047
356 FRUSTRATION TOLERANCE DECREASED 38 0.0047
357 ASTHENIA 1767 0.0047
358 SPINAL FUSION SURGERY 19 0.0047
359 HYPERSOMNIA 134 0.0047
360 POST PROCEDURAL INFECTION 38 0.0047
361 IRON DEFICIENCY ANAEMIA 43 0.0047
362 INTENTIONAL UNDERDOSE 34 0.0046
363 PRE-EXISTING CONDITION IMPROVED 29 0.0046
364 PRODUCT USE COMPLAINT 73 0.0046
365 DROOLING 32 0.0046
366 PRODUCT PRESCRIBING ERROR 110 0.0046
367 SENSORY LOSS 37 0.0046
368 GENERAL SYMPTOM 34 0.0045
369 POLYURIA 37 0.0045
370 RESPIRATORY DISORDER 135 0.0045
371 HAEMOGLOBIN ABNORMAL 29 0.0045
372 MULTIPLE ALLERGIES 35 0.0045
373 BLOOD SODIUM DECREASED 84 0.0045
374 UNDERDOSE 324 0.0044
375 VULVOVAGINAL BURNING SENSATION 27 0.0044
376 DECUBITUS ULCER 36 0.0044
377 MUSCULOSKELETAL DISCOMFORT 76 0.0044
378 HYPOKINESIA 64 0.0044
379 AMNESIA 285 0.0044
380 WEIGHT INCREASED 979 0.0044
381 KNEE OPERATION 43 0.0044
382 LYMPHOCYTE COUNT DECREASED 77 0.0044
383 HUMERUS FRACTURE 21 0.0044
384 FEELING HOT 266 0.0043
385 INFUSION SITE EXTRAVASATION 27 0.0043
386 OEDEMA 235 0.0043
387 HEADACHE 2713 0.0043
388 BRAIN FOG 67 0.0043
389 PRODUCT LABEL ISSUE 29 0.0043
390 ACCIDENT 51 0.0043
391 MACULAR DEGENERATION 51 0.0043
392 THIRST 75 0.0042
393 DEVICE OCCLUSION 59 0.0042
394 TEMPERATURE INTOLERANCE 43 0.0042
395 MUSCLE STRAIN 36 0.0042
396 HYSTERECTOMY 36 0.0042
397 HYPERVENTILATION 24 0.0041
398 NASAL CONGESTION 243 0.0041
399 NEURALGIA 100 0.0041
400 DYSGRAPHIA 27 0.0041
401 ORAL DISORDER 30 0.0041
402 PHARYNGEAL SWELLING 40 0.0041
403 ROSACEA 19 0.0041
404 SINUS CONGESTION 55 0.0041
405 HEAD DISCOMFORT 72 0.0041
406 EYE PAIN 229 0.0041
407 CEREBRAL DISORDER 30 0.0041
408 LIMB INJURY 110 0.0040
409 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 222 0.0040
410 FOOT OPERATION 20 0.0040
411 DYSPHAGIA 380 0.0040
412 PRODUCTIVE COUGH 191 0.0040
413 SALIVARY HYPERSECRETION 40 0.0040
414 POOR QUALITY SLEEP 86 0.0040
415 RESPIRATORY TRACT INFECTION 104 0.0040
416 PROSTATIC SPECIFIC ANTIGEN INCREASED 55 0.0040
417 NIGHTMARE 138 0.0040
418 GLOMERULAR FILTRATION RATE DECREASED 49 0.0040
419 ARTHRALGIA 1654 0.0040
420 PAIN IN EXTREMITY 1164 0.0039
421 ABNORMAL DREAMS 109 0.0039
422 FOREIGN BODY SENSATION IN EYES 25 0.0039
423 ROAD TRAFFIC ACCIDENT 164 0.0039
424 PNEUMONIA 1267 0.0039
425 GLAUCOMA 75 0.0039
426 DISABILITY 77 0.0039
427 DIPLOPIA 101 0.0039
428 SCOLIOSIS 24 0.0039
429 GROIN PAIN 34 0.0039
430 DIARRHOEA 2487 0.0038
431 INTERVERTEBRAL DISC PROTRUSION 84 0.0038
432 SINUSITIS 392 0.0038
433 ADVERSE EVENT 351 0.0038
434 THERAPY NON-RESPONDER 171 0.0038
435 RASH 1657 0.0038
436 APHONIA 53 0.0038
437 ABNORMAL FAECES 31 0.0038
438 PRODUCT DISTRIBUTION ISSUE 35 0.0038
439 ACCIDENTAL OVERDOSE 138 0.0038
440 ESCHERICHIA INFECTION 31 0.0038
441 LYMPHOEDEMA 26 0.0038
442 CELLULITIS 189 0.0037
443 OROPHARYNGEAL PAIN 347 0.0037
444 BLOOD PRESSURE DECREASED 249 0.0037
445 ANKLE FRACTURE 58 0.0037
446 LIGAMENT SPRAIN 37 0.0037
447 HYDRONEPHROSIS 28 0.0037
448 HYPERSENSITIVITY 693 0.0037
449 ATELECTASIS 36 0.0037
450 DECREASED ACTIVITY 40 0.0037
451 OSTEOPENIA 56 0.0037
452 RESTLESS LEGS SYNDROME 67 0.0037
453 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 664 0.0037
454 NERVE COMPRESSION 34 0.0037
455 EAR INFECTION 98 0.0037
456 APHASIA 111 0.0037
457 ILLNESS 378 0.0037
458 EXERCISE TOLERANCE DECREASED 21 0.0036
459 INTENTIONAL DOSE OMISSION 104 0.0036
460 BODY HEIGHT DECREASED 39 0.0036
461 DECREASED APPETITE 847 0.0036
462 BACK PAIN 845 0.0036
463 MULTIPLE SCLEROSIS RELAPSE 247 0.0036
464 HYPOACUSIS 155 0.0036
465 RENAL PAIN 38 0.0036
466 ROTATOR CUFF SYNDROME 46 0.0036
467 NEPHROLITHIASIS 164 0.0036
468 PERIPHERAL COLDNESS 49 0.0036
469 CANDIDA INFECTION 60 0.0035
470 VISION BLURRED 486 0.0035
471 SPINAL OSTEOARTHRITIS 31 0.0035
472 ORAL PAIN 79 0.0035
473 PSYCHIATRIC SYMPTOM 26 0.0035
474 SWOLLEN TONGUE 110 0.0035
475 COVID-19 617 0.0035
476 DYSPHONIA 205 0.0035
477 DERMATITIS ALLERGIC 44 0.0035
478 EXPIRED PRODUCT ADMINISTERED 116 0.0035
479 MOVEMENT DISORDER 112 0.0035
480 PULMONARY THROMBOSIS 38 0.0035
481 SARS-COV-2 TEST POSITIVE 46 0.0035
482 OEDEMA PERIPHERAL 424 0.0035
483 OCULAR DISCOMFORT 39 0.0035
484 PHARYNGITIS 43 0.0035
485 OFF LABEL USE 3012 0.0034
486 SPEECH DISORDER 180 0.0034
487 BRONCHITIS 254 0.0034
488 THERAPY CESSATION 176 0.0034
489 LIMB DISCOMFORT 106 0.0034
490 PAIN 2102 0.0034
491 FATIGUE 2663 0.0034
492 UPPER LIMB FRACTURE 68 0.0034
493 ATRIAL FIBRILLATION 332 0.0034
494 DISORIENTATION 135 0.0034
495 RENAL CYST 27 0.0034
496 HAND FRACTURE 24 0.0034
497 SPINAL DISORDER 32 0.0034
498 PERIORBITAL SWELLING 19 0.0034
499 GASTROINTESTINAL INFECTION 30 0.0033
500 RECTAL HAEMORRHAGE 143 0.0033
501 PNEUMONIA ASPIRATION 83 0.0033
502 FAECES DISCOLOURED 72 0.0033
503 HEART RATE INCREASED 328 0.0033
504 FLANK PAIN 31 0.0033
505 FEEDING DISORDER 67 0.0033
506 SKIN CANCER 71 0.0033
507 POOR VENOUS ACCESS 34 0.0033
508 TENSION 20 0.0033
509 LACRIMATION INCREASED 99 0.0033
510 FOOT FRACTURE 62 0.0033
511 PRODUCT PACKAGING ISSUE 31 0.0033
512 VISUAL IMPAIRMENT 404 0.0033
513 MUSCULOSKELETAL DISORDER 62 0.0033
514 ARTHROPOD BITE 24 0.0032
515 NERVE INJURY 36 0.0032
516 JOINT INJURY 69 0.0032
517 DECREASED INTEREST 19 0.0032
518 CLOSTRIDIUM DIFFICILE INFECTION 70 0.0032
519 UPPER RESPIRATORY TRACT INFECTION 148 0.0032
520 ERECTILE DYSFUNCTION 82 0.0032
521 FLATULENCE 181 0.0032
522 SOMNOLENCE 639 0.0032
523 ARTERIOSCLEROSIS CORONARY ARTERY 21 0.0032
524 ORAL DISCOMFORT 44 0.0032
525 IMPAIRED GASTRIC EMPTYING 43 0.0032
526 CHRONIC KIDNEY DISEASE 239 0.0031
527 MOTOR DYSFUNCTION 32 0.0031
528 RASH PRURITIC 170 0.0031
529 POST-TRAUMATIC STRESS DISORDER 21 0.0031
530 PARANOIA 54 0.0031
531 INGUINAL HERNIA 19 0.0031
532 TREMOR 518 0.0031
533 ARTHRITIS 244 0.0031
534 HYPOTHYROIDISM 99 0.0031
535 CARDIAC FLUTTER 20 0.0031
536 FUNGAL INFECTION 103 0.0031
537 TOOTH FRACTURE 34 0.0031
538 MASS 43 0.0031
539 HAEMORRHOIDS 60 0.0031
540 ORAL HERPES 60 0.0031
541 TENDON DISORDER 20 0.0031
542 HAEMATURIA 105 0.0031
543 FRACTURE 58 0.0031
544 OXYGEN SATURATION DECREASED 172 0.0031
545 SENSORY DISTURBANCE 49 0.0031
546 ONYCHOCLASIS 21 0.0030
547 HICCUPS 25 0.0030
548 SUBARACHNOID HAEMORRHAGE 31 0.0030
549 VITAMIN D DECREASED 26 0.0030
550 SURGERY 178 0.0030
551 VERTIGO 185 0.0030
552 THERAPEUTIC RESPONSE UNEXPECTED 136 0.0030
553 SKIN INFECTION 34 0.0030
554 INTERVERTEBRAL DISC DEGENERATION 28 0.0030
555 CORONAVIRUS INFECTION 20 0.0030
556 FACIAL PAIN 27 0.0030
557 FLUID RETENTION 153 0.0030
558 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 609 0.0030
559 CARDIAC FAILURE ACUTE 20 0.0030
560 PYELONEPHRITIS 26 0.0030
561 OROPHARYNGEAL DISCOMFORT 27 0.0030
562 VOMITING 1405 0.0030
563 DRUG INTERACTION 474 0.0030
564 DENTAL CARIES 33 0.0030
565 SENSITIVE SKIN 22 0.0030
566 BURNING SENSATION 209 0.0030
567 LOCALISED INFECTION 72 0.0030
568 MALAISE 1304 0.0030
569 FEELING ABNORMAL 711 0.0030
570 MUSCLE TIGHTNESS 48 0.0030
571 FEELING DRUNK 22 0.0030
572 COUGH 830 0.0030
573 INFECTION 428 0.0030
574 MUSCLE TWITCHING 68 0.0029
575 ATAXIA 35 0.0029
576 SNEEZING 66 0.0029
577 SLUGGISHNESS 30 0.0029
578 ARRHYTHMIA 139 0.0029
579 EYE INFLAMMATION 28 0.0029
580 HEART RATE IRREGULAR 66 0.0029
581 NODULE 38 0.0029
582 BREAST PAIN 31 0.0029
583 SPINAL PAIN 34 0.0029
584 PRODUCT DOSE OMISSION ISSUE 852 0.0029
585 SOMNAMBULISM 19 0.0029
586 FEELING JITTERY 55 0.0029
587 IMMUNODEFICIENCY 43 0.0029
588 COVID-19 PNEUMONIA 34 0.0029
589 OBSTRUCTIVE AIRWAYS DISORDER 32 0.0029
590 RHINITIS 23 0.0028
591 IMPAIRED QUALITY OF LIFE 41 0.0028
592 ADVERSE DRUG REACTION 256 0.0028
593 ASTHMA 322 0.0028
594 VITREOUS FLOATERS 28 0.0028
595 SMALL INTESTINAL OBSTRUCTION 35 0.0028
596 PALPITATIONS 332 0.0028
597 LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR 25 0.0028
598 INTRAOCULAR PRESSURE INCREASED 36 0.0028
599 HYPOPHAGIA 72 0.0028
600 DYSARTHRIA 106 0.0028
601 POST PROCEDURAL COMPLICATION 54 0.0028
602 PRESYNCOPE 68 0.0028
603 BODY TEMPERATURE INCREASED 57 0.0028
604 EYE DISCHARGE 29 0.0028
605 DYSPNOEA 1574 0.0028
606 NASAL DISCOMFORT 22 0.0028
607 WHITE BLOOD CELL COUNT INCREASED 106 0.0028
608 EYE IRRITATION 159 0.0028
609 PULMONARY MASS 41 0.0027
610 PELVIC PAIN 50 0.0027
611 OPTIC NEURITIS 25 0.0027
612 LETHARGY 158 0.0027
613 SPUTUM DISCOLOURED 26 0.0027
614 BEDRIDDEN 36 0.0027
615 ABDOMINAL PAIN 637 0.0027
616 THROAT TIGHTNESS 74 0.0027
617 SWELLING FACE 178 0.0027
618 SUBDURAL HAEMATOMA 39 0.0027
619 EYE SWELLING 101 0.0027
620 SECRETION DISCHARGE 34 0.0027
621 BLOOD COUNT ABNORMAL 41 0.0027
622 HIATUS HERNIA 35 0.0027
623 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 141 0.0027
624 BLOOD IRON DECREASED 32 0.0027
625 INFLUENZA 300 0.0027
626 PARKINSONISM 26 0.0027
627 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 90 0.0027
628 NAUSEA 2108 0.0027
629 LOSS OF CONSCIOUSNESS 341 0.0027
630 ACUTE CORONARY SYNDROME 22 0.0027
631 CATARACT 158 0.0027
632 ANGINA PECTORIS 76 0.0026
633 ERUCTATION 51 0.0026
634 PARAESTHESIA ORAL 38 0.0026
635 INTESTINAL OBSTRUCTION 99 0.0026
636 WEIGHT DECREASED 732 0.0026
637 CEREBRAL INFARCTION 64 0.0026
638 CHEST PAIN 483 0.0026
639 RESTLESSNESS 95 0.0026
640 SPINAL FRACTURE 52 0.0026
641 PERSONALITY CHANGE 24 0.0026
642 FACIAL PARALYSIS 22 0.0026
643 RESPIRATORY TRACT CONGESTION 41 0.0026
644 LABORATORY TEST ABNORMAL 76 0.0026
645 HEART RATE DECREASED 90 0.0026
646 CHOKING 50 0.0026
647 DISTURBANCE IN ATTENTION 138 0.0026
648 EYE DISORDER 84 0.0026
649 FULL BLOOD COUNT ABNORMAL 27 0.0026
650 CLOSTRIDIUM DIFFICILE COLITIS 27 0.0025
651 EAR DISCOMFORT 26 0.0025
652 RENAL DISORDER 118 0.0025
653 FLUSHING 257 0.0025
654 LIVER DISORDER 112 0.0025
655 SKIN LESION 69 0.0025
656 COORDINATION ABNORMAL 35 0.0025
657 ATRIAL FLUTTER 20 0.0025
658 PNEUMONIA BACTERIAL 23 0.0025
659 PRURITUS 961 0.0025
660 CARPAL TUNNEL SYNDROME 35 0.0025
661 DEPRESSED MOOD 132 0.0025
662 DIVERTICULITIS 69 0.0025
663 RETCHING 53 0.0025
664 STENT PLACEMENT 20 0.0025
665 SCHIZOPHRENIA 30 0.0025
666 DEHYDRATION 329 0.0025
667 GASTROINTESTINAL PAIN 27 0.0025
668 APHTHOUS ULCER 19 0.0024
669 EATING DISORDER 52 0.0024
670 BLOOD MAGNESIUM DECREASED 21 0.0024
671 PRODUCT DOSE OMISSION 158 0.0024
672 HERPES ZOSTER 139 0.0024
673 CYST 30 0.0024
674 RED BLOOD CELL COUNT DECREASED 69 0.0024
675 CEREBRAL HAEMORRHAGE 86 0.0024
676 ABNORMAL BEHAVIOUR 95 0.0024
677 DEVICE DISLOCATION 104 0.0024
678 HYPOTENSION 478 0.0024
679 THERAPEUTIC RESPONSE SHORTENED 79 0.0024
680 FEELING COLD 66 0.0024
681 DERMATITIS CONTACT 27 0.0024
682 MEDICATION ERROR 131 0.0024
683 ANXIETY 670 0.0024
684 TRANSIENT ISCHAEMIC ATTACK 79 0.0023
685 THROAT IRRITATION 105 0.0023
686 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 24 0.0023
687 HERNIA 45 0.0023
688 COLD SWEAT 41 0.0023
689 NEUROPATHY PERIPHERAL 220 0.0023
690 PANCREATITIS 122 0.0023
691 BASAL CELL CARCINOMA 36 0.0023
692 ADRENAL INSUFFICIENCY 28 0.0023
693 ELECTROCARDIOGRAM QT PROLONGED 83 0.0023
694 HEMIPARESIS 39 0.0023
695 PHOTOPHOBIA 43 0.0023
696 TINNITUS 105 0.0023
697 RENAL IMPAIRMENT 192 0.0023
698 BLOOD CALCIUM INCREASED 20 0.0023
699 TOOTH INFECTION 30 0.0023
700 MENTAL IMPAIRMENT 55 0.0023
701 HALLUCINATION, AUDITORY 36 0.0023
702 FEMUR FRACTURE 70 0.0023
703 RASH MACULAR 79 0.0023
704 TOOTH ABSCESS 23 0.0023
705 HOSPITALISATION 347 0.0023
706 HYPOAESTHESIA ORAL 34 0.0023
707 ABDOMINAL PAIN LOWER 57 0.0023
708 THINKING ABNORMAL 42 0.0023
709 BODY TEMPERATURE DECREASED 22 0.0022
710 LACERATION 21 0.0022
711 GOUT 40 0.0022
712 PRODUCT ADMINISTRATION ERROR 45 0.0022
713 BLOOD POTASSIUM INCREASED 36 0.0022
714 GASTROENTERITIS VIRAL 40 0.0022
715 COLON CANCER 33 0.0022
716 OCULAR HYPERAEMIA 105 0.0022
717 HYPERHIDROSIS 285 0.0022
718 TOOTH DISORDER 49 0.0022
719 FOETAL EXPOSURE DURING PREGNANCY 179 0.0022
720 SKIN FISSURES 43 0.0022
721 BLOOD GLUCOSE FLUCTUATION 24 0.0022
722 ILEUS 27 0.0022
723 WRIST FRACTURE 26 0.0022
724 BLOOD POTASSIUM DECREASED 65 0.0022
725 SKIN HAEMORRHAGE 32 0.0022
726 SYNCOPE 216 0.0022
727 NERVOUSNESS 112 0.0021
728 UNRESPONSIVE TO STIMULI 55 0.0021
729 PRURITUS GENERALISED 46 0.0021
730 MENTAL STATUS CHANGES 59 0.0021
731 RASH GENERALISED 55 0.0021
732 BIPOLAR DISORDER 23 0.0021
733 TACHYCARDIA 187 0.0021
734 HYPOKALAEMIA 97 0.0021
735 TOOTHACHE 38 0.0021
736 HAIR TEXTURE ABNORMAL 28 0.0021
737 TOOTH EXTRACTION 26 0.0021
738 HUNGER 29 0.0021
739 INFLUENZA LIKE ILLNESS 171 0.0021
740 EPISTAXIS 155 0.0021
741 PLATELET COUNT INCREASED 27 0.0021
742 BRAIN NEOPLASM 19 0.0021
743 TENDONITIS 32 0.0021
744 PROCEDURAL PAIN 57 0.0021
745 MUSCLE ATROPHY 26 0.0021
746 CHEST DISCOMFORT 208 0.0020
747 TENDON RUPTURE 25 0.0020
748 IMPAIRED DRIVING ABILITY 23 0.0020
749 DYSPNOEA EXERTIONAL 76 0.0020
750 MALIGNANT MELANOMA 27 0.0020
751 GASTRITIS 53 0.0020
752 ACUTE KIDNEY INJURY 308 0.0020
753 TRANSFUSION 21 0.0020
754 THROMBOSIS 161 0.0020
755 HEPATIC STEATOSIS 37 0.0020
756 TACHYPNOEA 27 0.0020
757 BLINDNESS UNILATERAL 28 0.0020
758 ACUTE RESPIRATORY FAILURE 38 0.0020
759 CEREBROVASCULAR ACCIDENT 333 0.0020
760 AGITATION 144 0.0020
761 PARALYSIS 28 0.0020
762 PNEUMOTHORAX 31 0.0020
763 VIRAL INFECTION 65 0.0020
764 EYE INFECTION 22 0.0019
765 THYROID DISORDER 30 0.0019
766 ANGIOEDEMA 86 0.0019
767 MOOD ALTERED 53 0.0019
768 MUSCULOSKELETAL CHEST PAIN 30 0.0019
769 SCAB 22 0.0019
770 COMPLICATION ASSOCIATED WITH DEVICE 28 0.0019
771 BLOOD TEST ABNORMAL 27 0.0019
772 EYE PRURITUS 64 0.0019
773 SEPSIS 212 0.0019
774 PULMONARY CONGESTION 25 0.0019
775 CARDIAC FAILURE CONGESTIVE 152 0.0019
776 VASCULITIS 22 0.0019
777 SEIZURE 218 0.0019
778 MYALGIA 318 0.0019
779 CARDIOMEGALY 23 0.0019
780 END STAGE RENAL DISEASE 34 0.0019
781 PYREXIA 641 0.0019
782 APATHY 27 0.0018
783 DEVICE ISSUE 166 0.0018
784 LYMPHOPENIA 26 0.0018
785 OSTEOMYELITIS 33 0.0018
786 PETECHIAE 19 0.0018
787 METASTASES TO LIVER 32 0.0018
788 PHARYNGEAL OEDEMA 28 0.0018
789 CENTRAL NERVOUS SYSTEM LESION 25 0.0018
790 DEVICE RELATED INFECTION 28 0.0018
791 HAEMATOCRIT DECREASED 36 0.0018
792 TUBULOINTERSTITIAL NEPHRITIS 34 0.0018
793 NEOPLASM MALIGNANT 121 0.0018
794 GASTRIC DISORDER 62 0.0018
795 CARDIAC DISORDER 169 0.0018
796 DYSTONIA 35 0.0018
797 PSYCHOTIC DISORDER 53 0.0018
798 SPLENOMEGALY 21 0.0018
799 MALNUTRITION 20 0.0018
800 OVERDOSE 385 0.0018
801 DRUG DISPENSING ERROR 27 0.0018
802 PLEURAL EFFUSION 107 0.0018
803 CHOLECYSTECTOMY 20 0.0017
804 SKIN DISORDER 58 0.0017
805 AGGRESSION 87 0.0017
806 HYPOMAGNESAEMIA 24 0.0017
807 DEAFNESS 45 0.0017
808 MENTAL DISORDER 74 0.0017
809 COLITIS ULCERATIVE 76 0.0017
810 PREGNANCY 34 0.0017
811 SKIN DISCOLOURATION 78 0.0017
812 ACUTE MYOCARDIAL INFARCTION 50 0.0017
813 BONE PAIN 99 0.0017
814 CARDIAC FAILURE 135 0.0017
815 INCREASED APPETITE 32 0.0017
816 WHITE BLOOD CELL COUNT DECREASED 181 0.0017
817 INTERNAL HAEMORRHAGE 19 0.0017
818 MOUTH ULCERATION 35 0.0017
819 PAIN IN JAW 47 0.0017
820 CHILLS 193 0.0016
821 AGEUSIA 41 0.0016
822 UNEVALUABLE EVENT 124 0.0016
823 FULL BLOOD COUNT DECREASED 33 0.0016
824 ELECTROLYTE IMBALANCE 19 0.0016
825 PULMONARY OEDEMA 73 0.0016
826 DEATH 1400 0.0016
827 SKIN ULCER 42 0.0016
828 DIABETES MELLITUS 123 0.0016
829 ERYTHEMA 330 0.0016
830 LOCAL SWELLING 28 0.0016
831 THERAPY PARTIAL RESPONDER 25 0.0016
832 IMMUNE SYSTEM DISORDER 21 0.0016
833 PRODUCT PHYSICAL ISSUE 32 0.0016
834 CHOLELITHIASIS 52 0.0016
835 DRY SKIN 211 0.0016
836 HAEMOPTYSIS 44 0.0016
837 EYE HAEMORRHAGE 21 0.0016
838 NERVOUS SYSTEM DISORDER 49 0.0016
839 ALTERED STATE OF CONSCIOUSNESS 34 0.0016
840 HYPONATRAEMIA 88 0.0016
841 SKIN REACTION 22 0.0016
842 HAEMATOMA 40 0.0015
843 DEVICE USE ISSUE 27 0.0015
844 PALLOR 42 0.0015
845 GENERALISED OEDEMA 19 0.0015
846 RESPIRATORY DISTRESS 42 0.0015
847 BLINDNESS 62 0.0015
848 HYPERKALAEMIA 53 0.0015
849 COLITIS 57 0.0015
850 HAEMORRHAGE INTRACRANIAL 22 0.0015
851 HAEMOGLOBIN DECREASED 151 0.0015
852 PRODUCT PRESCRIBING ISSUE 32 0.0015
853 GLYCOSYLATED HAEMOGLOBIN INCREASED 37 0.0015
854 MULTIPLE FRACTURES 24 0.0015
855 SCAR 25 0.0015
856 CRYING 53 0.0015
857 STAPHYLOCOCCAL INFECTION 48 0.0015
858 HYPOXIA 51 0.0014
859 PSYCHOMOTOR HYPERACTIVITY 24 0.0014
860 INTERSTITIAL LUNG DISEASE 70 0.0014
861 BLOOD GLUCOSE INCREASED 272 0.0014
862 RASH ERYTHEMATOUS 69 0.0014
863 DEPRESSED LEVEL OF CONSCIOUSNESS 57 0.0014
864 DYSGEUSIA 107 0.0014
865 BLOOD CREATININE INCREASED 94 0.0014
866 THERAPEUTIC RESPONSE DECREASED 87 0.0014
867 BLOOD UREA INCREASED 24 0.0014
868 HYPERGLYCAEMIA 52 0.0014
869 QUALITY OF LIFE DECREASED 19 0.0014
870 DRUG DOSE OMISSION 233 0.0014
871 PNEUMONITIS 38 0.0014
872 ANAPHYLACTIC REACTION 77 0.0014
873 BACTERIAL INFECTION 26 0.0014
874 ABSCESS 22 0.0014
875 WRONG TECHNIQUE IN DRUG USAGE PROCESS 50 0.0014
876 GASTROENTERITIS 20 0.0014
877 RENAL FAILURE 181 0.0014
878 ECZEMA 71 0.0014
879 SKIN EXFOLIATION 114 0.0013
880 TARDIVE DYSKINESIA 38 0.0013
881 LUNG NEOPLASM MALIGNANT 55 0.0013
882 PANIC ATTACK 48 0.0013
883 ANAEMIA 251 0.0013
884 NO ADVERSE EVENT 234 0.0013
885 SEPTIC SHOCK 56 0.0013
886 ANGER 43 0.0013
887 DERMATITIS ATOPIC 67 0.0013
888 ENCEPHALOPATHY 31 0.0013
889 PERICARDIAL EFFUSION 29 0.0013
890 ALANINE AMINOTRANSFERASE INCREASED 77 0.0013
891 HAEMATOCHEZIA 69 0.0012
892 DRUG EFFECT DECREASED 67 0.0012
893 EXTRA DOSE ADMINISTERED 50 0.0012
894 EMOTIONAL DISORDER 38 0.0012
895 GALLBLADDER DISORDER 22 0.0012
896 NEUTROPHIL COUNT DECREASED 50 0.0012
897 PHOTOSENSITIVITY REACTION 20 0.0012
898 BLOOD ALKALINE PHOSPHATASE INCREASED 30 0.0012
899 BONE DISORDER 22 0.0012
900 ASPARTATE AMINOTRANSFERASE INCREASED 64 0.0012
901 DEEP VEIN THROMBOSIS 77 0.0012
902 SEDATION 31 0.0012
903 MELAENA 26 0.0012
904 IRRITABILITY 71 0.0012
905 PLATELET COUNT DECREASED 125 0.0012
906 PULMONARY EMBOLISM 111 0.0012
907 INCORRECT DOSE ADMINISTERED 265 0.0012
908 INTERNATIONAL NORMALISED RATIO INCREASED 33 0.0012
909 BRADYCARDIA 61 0.0011
910 GASTROINTESTINAL HAEMORRHAGE 96 0.0011
911 DERMATITIS 24 0.0011
912 BLOOD GLUCOSE ABNORMAL 21 0.0011
913 HYPOGLYCAEMIA 55 0.0011
914 PSORIASIS 146 0.0011
915 RASH PAPULAR 25 0.0011
916 HYPOCALCAEMIA 21 0.0011
917 APPLICATION SITE PRURITUS 25 0.0011
918 INJECTION SITE URTICARIA 27 0.0011
919 PRODUCT STORAGE ERROR 95 0.0011
920 SUICIDAL IDEATION 99 0.0011
921 HAEMORRHAGE 113 0.0011
922 RENAL INJURY 32 0.0011
923 PULMONARY HYPERTENSION 22 0.0011
924 GASTRIC ULCER 20 0.0011
925 RESPIRATORY FAILURE 76 0.0010
926 INJECTION SITE MASS 38 0.0010
927 ABASIA 25 0.0010
928 DEVICE BREAKAGE 41 0.0010
929 FEAR 27 0.0010
930 MYOCARDIAL INFARCTION 174 0.0010
931 HEPATIC FUNCTION ABNORMAL 37 0.0010
932 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 29 0.0010
933 PRODUCT SUBSTITUTION ISSUE 57 0.0010
934 ANHEDONIA 26 0.0010
935 RHABDOMYOLYSIS 41 0.0010
936 PLASMA CELL MYELOMA 38 0.0010
937 MOOD SWINGS 31 0.0010
938 INJECTION SITE PRURITUS 65 0.0010
939 VISUAL ACUITY REDUCED 32 0.0010
940 NEEDLE ISSUE 28 0.0010
941 ACTIVITIES OF DAILY LIVING IMPAIRED 19 0.0010
942 INJECTION SITE BRUISING 76 0.0010
943 BLADDER CANCER 56 0.0010
944 DISEASE RECURRENCE 45 0.0009
945 DEVICE LEAKAGE 41 0.0009
946 PROSTATE CANCER 76 0.0009
947 BLOOD CREATINE PHOSPHOKINASE INCREASED 27 0.0009
948 PANCREATITIS ACUTE 21 0.0009
949 PANCYTOPENIA 52 0.0009
950 FEBRILE NEUTROPENIA 61 0.0009
951 LYMPHADENOPATHY 32 0.0009
952 GAMMA-GLUTAMYLTRANSFERASE INCREASED 20 0.0009
953 NEOPLASM PROGRESSION 31 0.0009
954 PAIN OF SKIN 24 0.0009
955 APPLICATION SITE ERYTHEMA 23 0.0009
956 DISEASE PROGRESSION 103 0.0009
957 BONE DENSITY DECREASED 27 0.0009
958 CORONARY ARTERY DISEASE 26 0.0009
959 BLOOD GLUCOSE DECREASED 41 0.0009
960 SKIN IRRITATION 39 0.0009
961 VAGINAL HAEMORRHAGE 36 0.0008
962 INTENTIONAL OVERDOSE 53 0.0008
963 LIVER FUNCTION TEST ABNORMAL 24 0.0008
964 EXPOSURE VIA SKIN CONTACT 21 0.0008
965 THROMBOCYTOPENIA 84 0.0008
966 WRONG TECHNIQUE IN DEVICE USAGE PROCESS 35 0.0007
967 BREAST CANCER FEMALE 20 0.0007
968 MALIGNANT NEOPLASM PROGRESSION 74 0.0007
969 INJECTION SITE RASH 22 0.0007
970 CARDIAC ARREST 58 0.0007
971 INJECTION SITE SWELLING 53 0.0007
972 INJECTION SITE PAIN 211 0.0007
973 ASCITES 20 0.0007
974 DEVICE MALFUNCTION 47 0.0007
975 WITHDRAWAL SYNDROME 28 0.0007
976 BREAST CANCER 61 0.0007
977 EMOTIONAL DISTRESS 78 0.0006
978 LEUKOPENIA 32 0.0006
979 INJECTION SITE ERYTHEMA 76 0.0006
980 SUICIDE ATTEMPT 37 0.0006
981 NEUTROPENIA 80 0.0006
982 PRODUCT ADHESION ISSUE 20 0.0006
983 DEVICE DIFFICULT TO USE 37 0.0006
984 ACCIDENTAL EXPOSURE TO PRODUCT 49 0.0005
985 COMA 22 0.0005
986 ACNE 30 0.0004
987 INJECTION SITE HAEMORRHAGE 31 0.0004
988 TOXICITY TO VARIOUS AGENTS 60 0.0004
989 SKIN BURNING SENSATION 25 0.0003
990 DRUG DOSE OMISSION BY DEVICE 20 0.0003